marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-02-2023
Evolent Health Balance Sheet 2011-2024 | EVH
Annual Balance Sheet Evolent Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
232 M | -43.5 M | -90.9 M | 194 M | -6.46 M | -117 M | 30.1 M | -146 M | - | -67.9 M | - | - |
Long Term Debt |
413 M | 216 M | 263 M | 294 M | 221 M | 121 M | 120 M | - | - | - | - | - |
Long Term Debt Current |
7.12 M | 7.07 M | 7.36 M | 6.27 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 376 M | 264 M | 134 M | 156 M | 21.4 M | 40.3 M | 41.6 M | - | - |
Total Current Liabilities |
433 M | 445 M | 402 M | 193 M | 269 M | 133 M | 132 M | 59.5 M | - | - | - | - |
Total Liabilities |
958 M | 726 M | 751 M | 569 M | 533 M | 266 M | 288 M | 80.9 M | 40.3 M | 70.9 M | - | - |
Deferred Revenue |
5.76 M | 11.9 M | 14.3 M | 19.8 M | 20.6 M | 24.8 M | 20.5 M | 14.8 M | - | 16.4 M | - | - |
Retained Earnings |
-606 M | -627 M | -589 M | -252 M | 50 M | 86 M | 147 M | 307 M | -25.8 M | - | - | - |
Total Assets |
1.82 B | 1.42 B | 1.37 B | 1.5 B | 1.72 B | 1.31 B | 1.2 B | 1.02 B | 38.3 M | 102 M | - | - |
Cash and Cash Equivalents |
188 M | 266 M | 362 M | 101 M | 228 M | 238 M | 135 M | 146 M | - | - | - | - |
Book Value |
859 M | 694 M | 620 M | 929 M | 1.19 B | 1.05 B | 912 M | 935 M | -2.07 M | 31 M | - | - |
Total Shareholders Equity |
859 M | 694 M | 620 M | 922 M | 1.14 B | 1.01 B | 703 M | 649 M | -2.07 M | 13.3 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet Evolent Health
| 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
600 M | - | 412 M | - | 283 M | 216 M | 211 M | 207 M | 202 M | 263 M | 263 M | 263 M | 297 M | 294 M | 228 M | 294 M | 294 M | 221 M | 221 M | 221 M | 221 M | 121 M | 121 M | 121 M | 121 M | 120 M | 120 M | 120 M | 120 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.4 B | - | 903 M | - | 728 M | 726 M | 646 M | 679 M | 688 M | 752 M | 752 M | 752 M | 604 M | 569 M | 569 M | 569 M | 569 M | 533 M | 533 M | 533 M | 533 M | 266 M | 266 M | 266 M | 266 M | 288 M | 288 M | 288 M | 288 M | 80.9 M | 80.9 M | 80.9 M | 80.9 M | - | 1.07 M | 1.07 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
5.76 M | - | 7.52 M | - | 13.3 M | 11.9 M | 13.8 M | 13.2 M | 13.4 M | 10.2 M | 10.2 M | 10.2 M | 17 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 20.6 M | 20.6 M | 20.6 M | 33.3 M | 24.8 M | 26.1 M | 27.8 M | 25.5 M | 20.5 M | 20.5 M | 20.5 M | 20.5 M | 14.8 M | 14.8 M | 14.8 M | 14.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-686 M | - | -595 M | - | -592 M | -627 M | -621 M | -608 M | -599 M | -589 M | -589 M | -589 M | -334 M | -252 M | -252 M | -252 M | -252 M | 50 M | 50 M | 50 M | 50 M | 86 M | 86 M | 86 M | 86 M | 147 M | 147 M | 147 M | 147 M | 307 M | 307 M | 307 M | 307 M | -25.8 M | -25.8 M | -25.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
2.67 B | - | 1.76 B | - | 1.34 B | 1.42 B | 1.25 B | 1.29 B | 1.31 B | 1.37 B | 1.37 B | 1.37 B | 1.45 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.72 B | 1.72 B | 1.72 B | 1.72 B | 1.31 B | 1.31 B | 1.31 B | 1.31 B | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.02 B | 1.02 B | 1.02 B | 1.02 B | 37.2 M | 38.3 M | 38.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
185 M | - | 157 M | - | 210 M | 266 M | 282 M | 207 M | 236 M | 319 M | 319 M | 319 M | 67.9 M | 101 M | 101 M | 101 M | 101 M | 228 M | 228 M | 228 M | 228 M | 238 M | 238 M | 238 M | 238 M | 135 M | 135 M | 135 M | 135 M | 146 M | 146 M | 146 M | 146 M | - | - | - | - | - | - | - | - | 5.25 M | - | - | - | - | - | - | - |
Book Value |
1.27 B | - | 856 M | - | 611 M | 694 M | 607 M | 614 M | 617 M | 620 M | 620 M | 620 M | 847 M | 929 M | 929 M | 929 M | 929 M | 1.19 B | 1.19 B | 1.19 B | 1.19 B | 1.05 B | 1.05 B | 1.05 B | 1.05 B | 912 M | 912 M | 912 M | 912 M | 935 M | 935 M | 935 M | 935 M | 37.2 M | 37.2 M | 37.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
1.1 B | - | 856 M | - | 611 M | 694 M | 607 M | 614 M | 617 M | 620 M | 620 M | 620 M | 847 M | 922 M | 922 M | 922 M | 922 M | 1.14 B | 1.14 B | 1.14 B | 1.14 B | 1.01 B | 1.01 B | 1.01 B | 1.01 B | 703 M | 703 M | 703 M | 703 M | 649 M | 649 M | 649 M | 649 M | -2.07 M | -2.07 M | -2.07 M | - | 13.3 M | - | - | - | 5.2 M | - | - | - | - | - | - | - |
All numbers in USD currency